Position in HRTX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$6,402
-$14,398 QoQ
Shares Held
15,000
-6.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#114
of 160 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $3,075,638 across 11 Biotechnology names. HRTX ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,414 | $702,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
958 | $597,351 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
2,722 | $509,776 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
16,906 | $427,721 | |
| 5 | EXEL |
Exelixis, Inc.
|
5,934 | $322,868 | |
| 6 | INCY |
Incyte Corp
|
2,210 | $250,525 | |
| 7 | VCEL |
Vericel Corp
|
4,700 | $209,103 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
11,269 | $19,833 |
All Filings in HRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,402 | 15,000 | Shares | Sole | 2026-07-21 | |
| 2025-12-31 | $20,800 | 16,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $20,160 | 16,000 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $33,120 | 16,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $35,200 | 16,000 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $22,950 | 15,000 | Shares | Sole | 2025-01-31 | |
| No filing history on record for this holder in this stock. | ||||||